Formaldehyde as an alternative to antibiotics for treatment of refractory impetigo and other infectious skin diseases

References

• Antimicrobial Use and Resistance in Australia. Second Australian report on antimicrobial use and resistance in human health. Sydney: Australian Commission on Safety and Quality in Health Care; 2017.
   Google Scholar
• Rojo P, Barrios M, Palacios A, et al. Community-associated Staphylococcus aureus infections in children. Expert Rev Anti Infect Ther. 2010;8(5):541–554.
   PubMed Web of Science ®Google Scholar
• Khodaverdian V, Pesho M, Truitt B, et al. Discovery of antivirulence agents against methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother. 2013;57(8):3645–3652.
   PubMed Web of Science ®Google Scholar
• Zhang G, Zhao Y, Paramasivan S, et al. Bacteriophage effectively kills multidrug resistant Staphylococcus aureus clinical isolates from chronic rhinosinusitis patients. Int Forum Allergy Rhinol. 2018;8(3):406–414.
   PubMed Web of Science ®Google Scholar
• Whitehall J, Kuzulugil D, Sheldrick K, et al. Burden of paediatric pyoderma and scabies in North West Queensland. J Paediatr Child Health. 2013;49(2):141–143.
   PubMed Web of Science ®Google Scholar
• Currie BJ, McCarthy JS. Permethrin and ivermectin for scabies. New Engl J Med. 2010;362(8):717–725.
   PubMed Web of Science ®Google Scholar
• Andriantsoanirina V, Izri A, Botterel F, et al. Molecular survey of knockdown resistance to pyrethroids in human scabies mites. Clin Microbiol Infect. 2014;20(2):139–141.
   Web of Science ®Google Scholar
• Salthammer T. The formaldehyde dilemma. Int J Hyg Environ Health. 2015;218(4):433–436.
   PubMed Web of Science ®Google Scholar
• Montanaro A. Formaldehyde in the workplace and in the home: exploring its clinical toxicology. Lab Med. 1996;27(11):752–757.
   Web of Science ®Google Scholar
• Chen NH, Djoko KY, Veyrier FJ, et al. Formaldehyde stress responses in bacterial pathogens. Front Microbiol. 2016;7:257.
   PubMed Web of Science ®Google Scholar
• Nielsen GD, Larsen ST, Wolkoff P. Re-evaluation of the WHO (2010) formaldehyde indoor air quality guideline for cancer risk assessment. Arch Toxicol. 2017;91(1):35–61.
   PubMed Web of Science ®Google Scholar
• Mazzola PG, Jozala AF, Novaes LCDL, et al. Minimal inhibitory concentration (MIC) determination of disinfectant and/or sterilizing agents. Braz J Pharm Sci. 2009;45(2):241–248.
   Web of Science ®Google Scholar
• Lo TS, Hammer KDP, Zegarra M, et al. Methenamine: a forgotten drug for preventing recurrent urinary tract infection in a multidrug resistance era. Expert Rev Anti Infect Ther. 2014;12(5):549–554.
   PubMed Web of Science ®Google Scholar
• Bartnik FG, Gloxhuber C, Zimmermann V. Percutaneous absorption of formaldehyde in rats. Toxicol Lett. 1985;25(2):167–172.
   PubMed Web of Science ®Google Scholar
• Lodén M. The in vitro permeability of human skin to benzene, ethylene glycol, formaldehyde, and n-hexane. Acta Pharmacol Toxicol. 1986;58(5):382–389.
   PubMedGoogle Scholar
• Kim KH, Jahan SA, Lee JT. Exposure to formaldehyde and its potential human health hazards. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev. 2011;29(4):277–299.
   PubMed Web of Science ®Google Scholar
• Moennich JN, Hanna DM, Jacob SE. Formaldehyde-releasing preservative in baby and cosmetic products: health risks related to exposure during infancy. J Dermatol Nurses Assoc. 2009;1(3):211–214.
   Google Scholar
• World Health Organization. WHO guidelines for indoor air quality: selected pollutants. Denmark: WHO Regional Office for Europe; 2010.
   Google Scholar
• Lang I, Bruckner T, Triebig G. Formaldehyde and chemosensory irritation in humans: a controlled human exposure study. Regul Toxicol Pharmacol. 2008;50(1):23–36.
   PubMed Web of Science ®Google Scholar
• Paustenbach D, Alarie Y, Kulle T, et al. A recommended occupational exposure limit for formaldehyde based on irritation. J Toxicol Environ Health Part A. 1997;50(3):217–264.
   PubMedGoogle Scholar
• Berglund B, Nordin S. Detectability and perceived intensity for formaldehyde in smokers and non-smokers. Chem Senses. 1992;17(3):291–306.
   Web of Science ®Google Scholar
• Cain WS, Schmidt R, Wolkoff P. Olfactory detection of ozone and d‐limonene: reactants in indoor spaces. Indoor Air. 2007;17(5):337–347.
   PubMed Web of Science ®Google Scholar
• Hauptmann M, Lubin JH, Stewart PA, et al. Mortality from solid cancers among workers in formaldehyde industries. Am J Epidemiol. 2004;159(12):1117–1130.
   PubMed Web of Science ®Google Scholar
• Bradman A, Gaspar F, Castorina R, et al. Formaldehyde and acetaldehyde exposure and risk characterization in California early childhood education environments. Indoor Air. 2017;27(1):104–113.
   PubMed Web of Science ®Google Scholar
• Oliveira M, Slezakova K, Delerue-Matos C, et al. Indoor air quality in preschools (3- to 5-year-old children) in the Northeast of Portugal during spring-summer season: pollutants and comfort parameters. J Toxicol Environ Health Part A. 2017;80(13–15):740–755.
   PubMed Web of Science ®Google Scholar
• Garrett MH, Hooper MA, Hooper BM, et al. Increased risk of allergy in children due to formaldehyde exposure in homes. Allergy. 1999;54(4):330–337.
   PubMed Web of Science ®Google Scholar
• McGwin G Jr, Lienert J, Kennedy JI Jr. Formaldehyde exposure and asthma in children: a systematic review. Environ Health Perspect. 2010;118(3):313–317.
   PubMed Web of Science ®Google Scholar
• Wantke F, Demmer CM, Tappler P, et al. Exposure to gaseous formaldehyde induces IgE-mediated sensitization to formaldehyde in school-children. Clin Exp Allergy. 1996;26(3):276–280.
   PubMed Web of Science ®Google Scholar
• Yao Y, Liang W, Zhu L, et al. Relationship between the concentration of formaldehyde in the air and asthma in children: a meta-analysis. Int J Clin Exp Med. 2015;8(6):8358–8362.
   PubMed Web of Science ®Google Scholar
• Golden R, Holm S. Indoor air quality and asthma: has unrecognized exposure to acrolein confounded results of previous studies? Dose Response. 2017;15(1):e1559325817691159.
   Web of Science ®Google Scholar
• De Groot AC, Flyvholm MA, Lensen G, et al. Formaldehyde‐releasers: relationship to formaldehyde contact allergy. Contact allergy to formaldehyde and inventory of formaldehyde‐releasers. Contact Derm. 2009;61(2):63–85.
   PubMed Web of Science ®Google Scholar
• Hauksson I, Pontén A, Isaksson M, et al. Formaldehyde in cosmetics in patch tested dermatitis patients with and without contact allergy to formaldehyde. Contact Derm. 2016;74(3):145–151.
   PubMed Web of Science ®Google Scholar
• Carlsen BC, Menné T, Johansen JD. 20 Years of standard patch testing in an eczema population with focus on patients with multiple contact allergies. Contact Derm. 2007;57(2):76–83.
   PubMed Web of Science ®Google Scholar
• Nair RG, Supe AN, Samsi AB. Formalin (0.25%) as topical anti-microbial agent in burns. J Postgrad Med. 1991;37(1):1–4.
   PubMedGoogle Scholar
• Iversen OH. Formaldehyde and skin carcinogenesis. Environ Int. 1986;12(5):541–544.
   Google Scholar
• Iversen OH. Formaldehyde and skin tumorigenesis in SENCAR mice. Environ Int. 1988;14(1):23–27.
   Web of Science ®Google Scholar
• Saito A, Tanaka H, Usuda H, et al. Characterization of skin inflammation induced by repeated exposure of toluene, xylene, and formaldehyde in mice. Environ Toxicol. 2011;26(3):224–232.
   PubMed Web of Science ®Google Scholar
• Jeffcoat AR, Chasalow F, Feldman DB. Disposition of [14C] formaldehyde after topical exposure to rats, guinea pigs, and monkeys. In: Gibson GE, editor. Formaldehyde toxicity. New York (NY): Hemisphere Publishing; 1983. p. 38–49.
   Google Scholar
• Bystrykh LV, Govorukhina NI, van Ophem PW, et al. Formaldehyde dismutase activities in gram-positive bacteria oxidizing methanol. Microbiology. 1993;139(9):1979–1985.
   Google Scholar
• Kümmerle N, Feucht HH, Kaulfers PM. Plasmid-mediated formaldehyde resistance in Escherichia coli: characterization of resistance gene. Antimicrob Agents Chemother. 1996;40(10):2276–2279.
   PubMed Web of Science ®Google Scholar
• Bowen AC, Mahé A, Hay RJ, et al. The global epidemiology of impetigo: a systematic review of the population prevalence of impetigo and pyoderma. PLoS ONE. 2015;10(8):e0136789.
   PubMed Web of Science ®Google Scholar
• Ghazvini P, Treadwell P, Woodberry K, et al. Impetigo in the pediatric population. J Dermatolog Clin Res. 2017;5(1):1092.
   Google Scholar
• Alsterholm M, Flytström I, Bergbrant IM, et al. Fusidic acid-resistant Staphylococcus aureus in impetigo contagiosa and secondarily infected atopic dermatitis. Acta Derm Venereol. 2010;90(1):52–57.
   PubMed Web of Science ®Google Scholar
• Poovelikunnel T, Gethin G, Humphreys H. Mupirocin resistance: clinical implications and potential alternatives for the eradication of MRSA. J Antimicrob Chemother. 2015;70(10):2681–2692.
   PubMed Web of Science ®Google Scholar
• Pereira LB. Impetigo – review. An Bras Dermatol. 2014;89(2):293–299.
   PubMed Web of Science ®Google Scholar
• Chambers HF, DeLeo FR. Waves of resistance: Staphylococcus aureus in the antibiotic era. Nat Rev Microbiol. 2009;7(9):629–641.
   PubMed Web of Science ®Google Scholar